Top 7 Mistakes to Avoid Before Launching Your Oncology or Rare Disease Product

Oct 22, 2021 7:18:20 PM

So you've developed a new drug for cancer. Or a treatment for a rare disease. You're getting good results from clinical trials, so you'll file for an NDA application in six months and hope the FDA — or the Oncology Center of Excellence (OCE) if you're developing a cancer product — will approve your drug in a couple of years. So far, so good. But what should you do right now?

Free Webinar Video Download

Read More

Converting the Data Lake into Actionable Insights with an Intelligent CRM

Mar 12, 2021 11:09:07 AM

Read More

Strategy is in the Eye of the Account Manager

Sep 30, 2020 3:54:41 PM

Strategic account planning. A well-known process within the medical device space that sometimes can be hard to prioritize and nail down. Streamlining the strategic account planning process will provide long-lasting benefits in the future. Medical device organizations that can nail down their strategy and modify it as needed will have a competitive advantage, especially with the right talent in place.

Read More

The Three Rs for Pharma Commercial Strategy

Sep 23, 2020 9:44:53 AM

In the pharmaceutical industry, a slew of interesting patterns and relationships have been identified as a result of COVID-19. When it comes to commercial organizations, it’s important that senior sales leaders stay on top of both internal and external trends in order to maintain a competitive edge and continue providing value to customers. More recently, it has become increasingly obvious that in the pharma industry, the impact of COVID-19 has sparked a need to modify the commercial model on all fronts.

Read More

MSLs Driving the Strategy Towards P&T Committees

Sep 14, 2020 1:10:25 PM

In pharma, there is a consistent trend we keep hearing that MSLs are experiencing a role shift in terms of their responsibilities and which key stakeholders they engage with. With organized planning and the right data capabilities, MSLs are better positioned for driving the strategy towards P&T committees when medications are ready to be evaluated for formulary inclusion. 

Read More

Three Key Considerations for Commercial and Market Access Teams

Sep 8, 2020 11:48:37 AM

Three Key Considerations for Commercial and Market Access Teams

Silos. We’ve all heard of this term in the pharmaceutical industry however, do most of us truly understand how negatively silos affect internal and external collaboration? Long-term, consistent, and inefficient collaboration can seriously impact an organization’s bottom line. Especially when it comes to the commercialization process, collaboration is a necessity. Whether a product is going through the launch cycle or it has been on the market for quite some time, it is important that market access teams and commercial teams are consistently collaborating. 

Read More

The Formulary Speaks for Itself, or Does It?

Aug 28, 2020 2:26:14 PM

Blog-Banner-fomulary

There are many factors that need to be taken into consideration when optimizing and accelerating market access. One of the first items that should be on your checklist is honing in on a strong messaging and engagement strategy when targeting payers. In understanding what messaging most resonates with payers, market access, commercial, and marketing teams can gauge where value is perceived according to each payer. 

Read More

TikaMobile Featured in PharmaTech Outlook Magazine, Enterprise Software Edition

Aug 24, 2020 1:29:45 PM

This August, TikaMobile made the cover the Pharma Tech Outlook Enterprise Software 2020 Magazine. Nominated as a top 10 Pharma Enterprise Solutions provider, TikaMobile's feature includes a write up depicting how the company is alleviating Covid-19 pressure for the Life Sciences industry with remote collaboration capabilities.

Manish-Magazine-Cover

Read More

Meaningful Data for Meaningful Remote Engagements

Aug 21, 2020 9:30:12 AM

Blog-Banner-Meaningful-data-for-remote-engagements-1

The digital transformation is changing the way pharmaceutical companies interact with healthcare professionals (HCPs). Life sciences decision-makers need to equip their teams with powerful data to help them best capitalize on HCP communication preferences as well as their geographic, therapeutic area, specialty, and patient mix. With email automation and virtual conferencing capabilities on the rise, embracing digital innovation by working around the pandemic will allow organizations to best decide how to target physicians for the most meaningful interactions.

Read More

Keep Your Data Close and Your KOLs Closer

Aug 13, 2020 1:18:07 PM

It is no question that the COVID-19 pandemic has made in-person engagement much more difficult. As a result, organizations are struggling to maintain relationships with key stakeholders. For pharmaceutical and medical device organizations, medical affairs and sales teams are grounded, making strong targeting and engagement strategies even more imperative in order to gain a competitive advantage. 

Read More

LATEST NEWS